• Correction: Reduced expression of the psychiatric risk gene DLG2 (PSD93) impairs hippocampal synaptic integration and plasticity
  Published on 2024-01-14
  3 years ago
• Sex-specific resting state brain network dynamics in patients with major depressive disorder
  Published on 2024-01-12
  3 years ago
• Correction: The effects of experience of discrimination and acculturation during pregnancy on the developing offspring brain
  Published on 2024-01-10
  3 years ago
• Amplitude-determined seizure-threshold, electric field modeling, and electroconvulsive therapy antidepressant and cognitive outcomes
  Published on 2024-01-10
  3 years ago
• Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player?
  Published on 2024-01-10
  3 years ago
• Effects of open access publishing on article metrics in Neuropsychopharmacology
  Published on 2024-01-10
  3 years ago
• Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder
  Published on 2024-01-09
  3 years ago

« Previous 1 … 108 109 110 111 112 … 143 Next »

• Developing a new national MDMA policy: Results of a multi-decision multi-criterion decision analysis
  Published on 2021-02-03
  6 years ago
• Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports
  Published on 2021-01-11
  6 years ago
• Does variation in trait schizotypy and frequency of cannabis use influence the acute subjective, cognitive and psychotomimetic effects of delta-9-tetrahydrocannabinol? A mega-analysis
  Published on 2021-01-09
  6 years ago
• Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice
  Published on 2021-01-09
  6 years ago
• Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD
  Published on 2021-01-09
  6 years ago
• Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity
  Published on 2021-01-09
  6 years ago
• Pharmacological uses of flumazenil in benzodiazepine use disorders: a systematic review of limited data
  Published on 2021-01-09
  6 years ago

« Previous 1 … 108 109 110 111 112 … 154 Next »

• Refining biomarker evaluation in ASD
  Published on 2021-04-30
  5 years ago
• CBD is not converted to THC in rats: A framework interpretation and discussion
  Published on 2021-04-28
  5 years ago
• Ketamine treatment upon memory retrieval reduces fear memory in marmoset monkeys
  Published on 2021-04-26
  5 years ago
• Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study
  Published on 2021-04-26
  5 years ago
• Bipolar disorder cohort studies: Crucial, but underfunded
  Published on 2021-04-23
  5 years ago
• Anterior cingulate cortex neuro-metabolic changes underlying lithium-induced euthymia in bipolar depression: A longitudinal 1H-MRS study
  Published on 2021-04-19
  5 years ago
• Editorial
  Published on 2021-04-17
  5 years ago

« Previous 1 … 108 109 110 111 112 … 170 Next »